Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas
PaperCitations, authors & open-access status
Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 98 citations, 2023 year and hybrid oa status.
98
Citations
2023
Year
hybrid
OA Status